Company Filing History:
Years Active: 2025
Title: Menglu Lyu: Innovator in Nucleic Acid Editing
Introduction
Menglu Lyu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of genetic engineering, particularly in nucleic acid editing technologies. Her innovative work has the potential to impact various applications in agriculture and medicine.
Latest Patents
Menglu Lyu holds a patent for the CRISPR/Cas12J enzyme and system. This patent includes a Cas effector protein, a fusion protein containing said protein, and a nucleic acid molecule coding for the same. Additionally, it provides a complex and a composition for nucleic acid editing, which can be utilized for gene or genome editing. The patent also outlines a method for nucleic acid editing using the Cas effector protein or the fusion protein.
Career Highlights
Menglu Lyu is affiliated with China Agricultural University, where she conducts her research and development. Her work in the field of CRISPR technology has garnered attention and recognition within the scientific community. She has been instrumental in advancing the understanding and application of gene editing techniques.
Collaborations
Menglu collaborates with notable colleagues, including Jinsheng Lai and Yingsi Zhou. Their combined expertise enhances the research efforts and innovation in the field of genetic engineering.
Conclusion
Menglu Lyu is a key figure in the realm of nucleic acid editing, with her patent on the CRISPR/Cas12J enzyme showcasing her innovative contributions. Her work at China Agricultural University continues to pave the way for advancements in genetic research and applications.